FDMT · Company research
4D Molecular Therapeutics, Inc. Common Stock (FDMT): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
13records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| OCUL, FDMT Stock Clock Best Day In Weeks After EyePoint’s Trial Setback — Here’s Why - Stocktwits | OCUL, FDMT Stock Clock Best Day In Weeks After EyePoint’s Trial Setback — Here’s Why Stocktwits | View source ↗ | Stocktwits | Oct 8, 2026 | neutral | 0 | 0.6 |
| CEO David Kirn sells 58,061 and 272 shares of 4D Molecular Therapeutics (FDMT) under a trading plan. - Stock Titan | CEO David Kirn sells 58,061 and 272 shares of 4D Molecular Therapeutics (FDMT) under a trading plan. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| 4D Molecular Therapeutics (NasdaqGS:FDMT) Stock Forecast & Analyst Predictions - Simply Wall Street | 4D Molecular Therapeutics (NasdaqGS:FDMT) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 6, 2026 | neutral | 0 | 0.6 |
| Officer David Kirn plans to sell 58,333 shares of 4D Molecular Therapeutics (FDMT). - Stock Titan | Officer David Kirn plans to sell 58,333 shares of 4D Molecular Therapeutics (FDMT). Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| $FDMT stock is down 8% today. Here's what we see in our data. - Quiver Quantitative | $FDMT stock is down 8% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 5, 2026 | neutral | 0 | 0.6 |
| Four retinal specialists will join company leaders in New York to discuss retinal disease treatment. - Stock Titan | Four retinal specialists will join company leaders in New York to discuss retinal disease treatment. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| OCUL Stock Suffers Sharpest Drop Since February As KOD And FDMT Post Updates On Their Wet AMD Drugs - Stocktwits | OCUL Stock Suffers Sharpest Drop Since February As KOD And FDMT Post Updates On Their Wet AMD Drugs Stocktwits | View source ↗ | Stocktwits | Sep 28, 2026 | neutral | 0 | 0.6 |
| FDMT: 4D Molecular Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits | FDMT: 4D Molecular Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas Stocktwits | View source ↗ | Stocktwits | Sep 22, 2026 | neutral | 0 | 0.6 |
| OCUL, FDMT Stock Clock Best Day In Weeks After EyePoint’s Trial Setback — Here’s Why - TradingView | OCUL, FDMT Stock Clock Best Day In Weeks After EyePoint’s Trial Setback — Here’s Why TradingView | View source ↗ | TradingView | Aug 17, 2026 | neutral | 0 | 0.6 |
| 4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance | 4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Tops Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Aug 13, 2026 | neutral | 0 | 0.6 |
| FDMT Forecast — Price Target — Prediction for 2027 - TradingView | FDMT Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Strength Seen in 4D Molecular Therapeutics (FDMT): Can Its 7.9% Jump Turn into More Strength? - Yahoo Finance | Strength Seen in 4D Molecular Therapeutics (FDMT): Can Its 7.9% Jump Turn into More Strength? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 23, 2026 | neutral | 0 | 0.6 |
| 4D Molecular Therapeutics Inc (FDMT): Gene Therapy Stock Made for You? - Yahoo Finance | 4D Molecular Therapeutics Inc (FDMT): Gene Therapy Stock Made for You? Yahoo Finance | View source ↗ | Yahoo Finance | May 20, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.